An immunological link between Candida albicans colonization and Crohn's disease

Critical Reviews in Microbiology

Volumn 41, Issue 2, 2015, Pages 135-139

  Gerard, Romain ^a,b,c,e   Sendid, Boualem ^a,b,d,e   Colombel, Jean Frederic ^a,b,c,e   Poulain, Daniel ^a,b,d,e   Jouault, Thierry ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c Service des Maladies de l'Appareil Digestif et de la Nutrition   (France)

^d Institut de Microbiologie   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antigens; Inflammation; Innate adaptive immune response; Pathogen associated molecular patterns

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; FUNGUS ANTIBODY; FUNGUS ANTIGEN; GLYCAN; INFLAMMASOME; NEUTROPHIL CYTOPLASMIC ANTIBODY; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CANDIDA ALBICANS; COMMENSAL; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FUNGAL COLONIZATION; FUNGUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH17 CELL; YEAST; EUROPE; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS;

CANDIDA ALBICANS; CROHN DISEASE; EUROPE; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS;

EID: 84929745873     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2013.810587     Document Type: Review

References (56)

1. Abraham C, Cho J. (2009). Inflammatory bowel disease. N Engl J Med 361:2066-78
2. Barrett JC, Hansoul S, Nicolae DL, et al. (2008). Genome-wiDe association Defines more than 30 distinct susceptibility loci for Crohns disease. Nat Genet 40:955-62
3. Bernhardt H, Knoke M. (1997). Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol Suppl 222:102-6
4. Brand S. (2009). Crohns disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohns disease. Gut 58:1152-67
5. Brown GD, Gordon S. (2001). Immune recognition. A new receptor for beta-glucans. Nature 413:36-7
6. Brown GD, Herre J, Williams DL, et al. (2003). Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197:1119-24
7. Cheng SC, Van De Veerdonk FL, Lenardon M, et al. (2011) the Dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol 90:357-66
8. Cho J. (2008) the genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458-66
9. Chouraki V, Savoye G, Dauchet L, et al. (2011) the changing pattern of Crohns disease inciDence in northern France: a continuing increase in the 10-to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 33:1133-42
10. Colombel JF, Sendid B, Jouault T, Poulain D. (2013). Secukinumab failure in Crohns disease: the yeast connection? Gut 62:800-1
11. Darfeuille-Michaud A, BouDeau J, Bulois P, et al. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohns disease. Gastroenterology 127:412-21
12. Deretic V. (2012). Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21-31
13. Dotan I, Fishman S, Dgani Y, et al. (2006). Antibodies against laminaribiosiDe and chitobiosiDe are novel serologic markers in Crohns disease. Gastroenterology 131:366-78
14. Eyerich K, Foerster S, Rombold S, et al. (2008). Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-Associated cytokines IL-17 and IL-22. J Invest Dermatol 128:2640-5
15. Ferrante M, Henckaerts L, Joossens M, et al. (2007). New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56:1394-403
16. Franke A, McGovern DPB, Barrett JC, et al. (2010). Genome-wiDe metaanalysis increases to 71 the number of confirmed Crohns disease susceptibility loci. Nat Genet 42:1118-25
17. Gantner BN, Simmons RM, UnDerhill DM. (2005). Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24:1277-86
18. Gladiator A, Wangler N, Trautwein-Weidner K, Leibundgut-Landmann S. (2012). Cutting Edge: IL-17-secreting innate lymphoid cells are essential for host Defense against fungal infection. J Immunol 190: 521-5
19. Gow NA, Van De Veerdonk FL, Brown AJ, Netea MG. (2012). Candida albicans morphogenesis and host Defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112-22
20. Hueber W, Sands BE, Lewitzky S, et al. (2012). Secukinumab, a human anti-IL-17A monoclonal antibody, for moDerate to severe Crohns disease: unexpected results of a randomised, double-blind placebocontrolled trial. Gut 61:1693-700
21. Hugot J, Chamaillard M, Zouali H, et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease. Nature 411:599-603
22. Iliev ID, Funari VA, Taylor KD, et al. (2012). Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314-7
23. Jawhara S, Thuru X, Standaert-Vitse A, et al. (2008). Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 197:972-80
24. Jouault T, El Abed-El Behi M, Martinez-Esparza M, et al. (2006). Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177:4679-87
25. Jouault T, Sarazin A, Martinez-Esparza M, et al. (2009). Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol 11: 1007-15
26. Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro I. (2010). Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to Candida, a luminal antigen. Pediatr Allergy Immunol 21: 747-55
27. Li X, Conklin L, Alex P. (2008). New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 14:5115-24
28. Macfarlan G, Blackett K, Nakayama T, et al. (2009) the gut microbiota in inflammatory bowel disease. Curr Pharm Des 15:1528-36
29. McGovern D, Powrie F. (2007) the IL23 axis plays a key role in the pathogenesis of IBD. Gut 56:1333-6
30. McKenzie H, Main J, Pennington C, Parratt D. (1990). Antibody to selected strains of Saccharomyces cerevisiae (bakers and brewers yeast) and Candida albicans in Crohns disease. Gut 31:536-8
31. Milner JD, Brenchley JM, Laurence A, et al. (2008). Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-6
32. Nerich V, Monnet E, Etienne A, et al. (2006). Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12:218-26
33. Nicola AM, Albuquerque P, Martinez LR, et al. (2012). Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun 80:3065-76
34. Ott SJ, Kuhbacher T, Musfeldt M, et al. (2008). Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831-41
35. Perlroth J, Choi B, Spellberg B. (2007). Nosocomial fungal infections: epiDemiology, diagnosis, and treatment. Med Mycol 45:321-46
36. Poulain D, Sendid B, Standaert-Vitse A, et al. (2009). Yeasts: neglected pathogens. Digest Dis 27:104-10
37. Quinton JF, Sendid B, Reumaux D, et al. (1998). Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788-91
38. Rehaume LM, Jouault T, Chamaillard M. (2010). Lessons from the inflammasome: a molecular sentry linking Candida and Crohns disease. Trends Immunol 31:171-5
39. RieDer F, Lopez R, Franke A, et al. (2011). Characterization of changes in serum anti-glycan antibodies in Crohns disease-A longitudinal analysis. PLoS ONE 6:e18172
40. Roberts RL, Topless RKG, Phipps-Green AJ, et al. (2010). EviDence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohns disease. Genes Immun 11:351-6
41. Saitoh T, Fujita N, Jang MH, et al. (2008). Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456:264-8
42. Sartor R. (2008). Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-94
43. Seksik P, Rigottier-Gois L, Gramet G, et al. (2003). Alterations of the dominant faecal bacterial groups in patients with Crohns disease of the colon. Gut 52:237-42
44. Sendid B, Colombel JF, Jacquinot PM, et al. (1996). Specific antibody response to oligomannosidic epitopes in Crohns disease. Clin Diagn Lab Immunol 3:219-26
45. Sendid B, Dotan N, Nseir S, et al. (2008). Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 15:1868-77
46. Sendid B, Jouault T, Vitse A, et al. (2009). Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease. Med Sci 25:473-81
47. Sendid B, Quinton JF, Charrier G, et al. (1998). Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohns disease. Am J Gastroenterol 93:1306-10
48. Shi CS, ShenDerov K, Huang NN, et al. (2012). Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for Destruction. Nat Immunol 13: 255-63
49. Sokol H, Seksik P, Furet JP, et al. (2009). Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15:1183-9
50. Standaert-Vitse A, Jouault T, VanDewalle P, et al. (2006). Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohns disease. Gastroenterology 130:1764-75
51. Standaert-Vitse A, Sendid B, Joossens M, et al. (2009). Candida albicans colonization and ASCA in familial Crohns disease. Am J Gastroenterol 104:1745-53
52. Travassos LH, Carneiro LA, Girardin S, Philpott DJ. (2010). Nod proteins link bacterial sensing and autophagy. Autophagy 6:409-11
53. Van Limbergen J, Wilson D, Satsangi J. (2009) the genetics of Crohns disease. Annu Rev Genomics Hum Genet 10:89-116
54. Vasseur F, Sendid B, Jouault T, et al. (2012). Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohns disease and anti-saccharomyces cerevisiae antibody levels. Inflamm Bowel Dis 18:430-8
55. WilDenberg ME, Vos AC, Wolfkamp SC, et al. (2012). Autophagy attenuates the adaptive immune response by Destabilizing the immunologic synapse. Gastroenterology 142:1493-503
56. Zelante T, De Luca A, DAngelo C, et al. (2009). IL-17/Th17 in antifungal immunity: whats new? Eur J Immunol 39:645-8